| Nikola Bicak, DPM | |
|
1837 Ripley Rd, Ripley, WV 25271-5113 | |
| (304) 372-3788 | |
| (304) 372-1513 |
| Full Name | Nikola Bicak |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 30 Years |
| Location | 1837 Ripley Rd, Ripley, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093710527 | NPI | - | NPPES |
| 0099957000 | Medicaid | WV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 307 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jackson General Hospital | Ripley, WV | Hospital |
| Provider Name | Giaimo Mobile Podiatry Of Wv Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1386183473 PECOS PAC ID: 1850666751 Enrollment ID: O20171003005473 |
News Archive
Eribis Pharmaceuticals AB - part of the Karolinska Development portfolio - announced today that it has received follow-on financial investment enabling the company to continue its clinical development program. Based on cardio-protective effects, Eribis' candidate drug has the potential to become an important new therapy for treating acute coronary syndrome (ACS) and reperfusion injury (damage to tissue caused when blood supply returns after a period of ischemia), as well as for surgical preconditioning. The new round of investment from Karolinska Development AB will allow Eribis to strengthen the preclinical material.
A natural compound found in grape seed extract could be used to strengthen dentin - the tissue beneath a tooth's enamel - and increase the life of resin fillings, according to new research at the University of Illinois at Chicago College of Dentistry.
The United States Food and Drug Administration ("FDA") is cracking down on the importation of unapproved new drugs with regards to personal use. Import Alert #66-41, "Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S." ("IA 66-41") was most recently published on September 23, 2010. IA 66-41 contains a Red List, a list of importers whose products are automatically detained for FDA violations, of over 400 firms on the charge of importing misbranded unapproved new drugs. Benjamin England, founder of FDAImports.com, LLC and former FDA Compliance Officer, attorney, and Food and Drug Law expert states that "This Import Alert has been expanded to include importers and products of drugs imported strictly for personal use rather than just targeting foreign shippers, which is FDA's normal M.O."
A new Boston University School of Public Health (BUSPH) study finds that the proportion of high school students identifying as lesbian, gay, bisexual, or questioning (LGBQ) doubled from 2009 to 2017, while the LGBQ teen rate of attempted suicide went from five times the rate for their straight peers to nearly four times the rate.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nikola Bicak, DPM Po Box 796, Ripley, WV 25271-0796 Ph: (304) 372-3788 | Nikola Bicak, DPM 1837 Ripley Rd, Ripley, WV 25271-5113 Ph: (304) 372-3788 |
News Archive
Eribis Pharmaceuticals AB - part of the Karolinska Development portfolio - announced today that it has received follow-on financial investment enabling the company to continue its clinical development program. Based on cardio-protective effects, Eribis' candidate drug has the potential to become an important new therapy for treating acute coronary syndrome (ACS) and reperfusion injury (damage to tissue caused when blood supply returns after a period of ischemia), as well as for surgical preconditioning. The new round of investment from Karolinska Development AB will allow Eribis to strengthen the preclinical material.
A natural compound found in grape seed extract could be used to strengthen dentin - the tissue beneath a tooth's enamel - and increase the life of resin fillings, according to new research at the University of Illinois at Chicago College of Dentistry.
The United States Food and Drug Administration ("FDA") is cracking down on the importation of unapproved new drugs with regards to personal use. Import Alert #66-41, "Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S." ("IA 66-41") was most recently published on September 23, 2010. IA 66-41 contains a Red List, a list of importers whose products are automatically detained for FDA violations, of over 400 firms on the charge of importing misbranded unapproved new drugs. Benjamin England, founder of FDAImports.com, LLC and former FDA Compliance Officer, attorney, and Food and Drug Law expert states that "This Import Alert has been expanded to include importers and products of drugs imported strictly for personal use rather than just targeting foreign shippers, which is FDA's normal M.O."
A new Boston University School of Public Health (BUSPH) study finds that the proportion of high school students identifying as lesbian, gay, bisexual, or questioning (LGBQ) doubled from 2009 to 2017, while the LGBQ teen rate of attempted suicide went from five times the rate for their straight peers to nearly four times the rate.
› Verified 9 days ago
Nikola Bicak Dba Jackson Foot & Ankle Clinic Podiatrist Medicare: Medicare Enrolled Practice Location: 844 Route 62 South, Ripley, WV 25271 Phone: 304-372-3788 Fax: 304-372-1513 | |
Dr. Jacob Meisenburg, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 122 Pinnell St, Ripley, WV 25271 Phone: 304-372-2731 Fax: 304-372-2749 |